Correlation Between Anebulo Pharmaceuticals and Conduit Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Conduit Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Conduit Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anebulo Pharmaceuticals and Conduit Pharmaceuticals, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Conduit Pharmaceuticals.

Diversification Opportunities for Anebulo Pharmaceuticals and Conduit Pharmaceuticals

0.56

Correlation Coefficient

Anebulo Pharmaceuticals  Conduit Pharmaceuticals

Very weak diversification

The 3 months correlation between Anebulo and Conduit is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Conduit Pharmaceuticals go up and down completely randomly.

Pair Corralation between Anebulo Pharmaceuticals and Conduit Pharmaceuticals

Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to generate 0.72 times more return on investment than Conduit Pharmaceuticals. However, Anebulo Pharmaceuticals is 1.39 times less risky than Conduit Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Conduit Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest  295.00  in Anebulo Pharmaceuticals on October 7, 2024 and sell it today you would lose (130.00) from holding Anebulo Pharmaceuticals or give up 44.07% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Anebulo Pharmaceuticals  vs.  Conduit Pharmaceuticals

Anebulo Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical and fundamental indicators, Anebulo Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Conduit Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Conduit Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Conduit Pharmaceuticals is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Anebulo Pharmaceuticals and Conduit Pharmaceuticals

The main advantage of trading using opposite Anebulo Pharmaceuticals and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.

The idea behind Anebulo Pharmaceuticals and Conduit Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.